Fluidigm: 4 Different Insiders Have Sold Shares During The Last 30 Days

| About: Fluidigm Corporation (FLDM)

In this article, I will feature one tech stock that has seen intensive insider selling during the last 30 days. Intensive insider selling can be defined by the following three criteria:

  1. The stock was sold by three or more insiders within one month.
  2. The stock was not purchased by any insiders in the month of intensive selling.
  3. At least two sellers decreased their holdings by more than 10%.

Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems for academic research institutions, clinical laboratories, pharmaceutical companies, and biotechnology and Ag-Bio companies.

Insider selling during the last 30 days

Here is a table of Fluidigm's insider-trading activity during the last 30 days by insider.

Name Title Trade Date Shares Sold Rule 10b5-1 Current Ownership Decrease In Ownership
Robert Jones EVP Dec 31 3,500 Yes 0 shares + 6,965 options 33.4%
Gajus Worthington CEO Dec 16-Jan 2 12,000 Yes 53,159 shares 18.4%
Fredric Walder COO Dec 16 1,500 Yes 0 shares + 8,227 options 15.4%
Vikram Jog CFO Dec 9 3,957 Yes 0 shares + 48,235 options 7.6%

There have been 20,957 shares sold by insiders during the last 30 days. All these shares were sold pursuant to a Rule 10b5-1 plan.

SEC Rule 10b5-1 is a regulation enacted by the United States Securities and Exchange Commission (SEC) in 2000. The SEC states that Rule 10b5-1 was enacted in order to resolve an unsettled issue over the definition of insider trading, which is prohibited by SEC Rule 10b-5. After Rule 10b5-1 was enacted, the SEC staff publicly took the position that canceling a planned trade made under the safe harbor does not constitute insider trading, even if the person was aware of the inside information when canceling the trade. This staff interpretation raises the possibility that executives can exploit this safe harbor by entering into 10b5-1 trading plans before they have inside information while retaining the option to later cancel those plans based on inside information.

For example, a CEO of a company could call a broker on January 1 and enter into a plan to sell a particular quantity of shares of his company's stock on March 1, find out terrible news about his company on February 1 that will not become public until April 1, and then go forward with the March 1 sale anyway, saving himself from losing money when the bad news becomes public. Under the terms of Rule 10b5-1(b) this is insider trading because the CEO "was aware" of the inside information when he made the trade. But he can assert an affirmative defense under Rule 10b5-1(c), because he planned the trade before he learned the inside information.

In general, it is a safer way for an insider to sell shares pursuant to a Rule 10b5-1 trading plan than without it.

Insider selling by calendar month

Here is a table of Fluidigm's insider-trading activity by calendar month.

Month Insider selling / shares Insider buying / shares
January 2013 6,000 0
December 2013 23,180 0
November 2013 96,423 0
October 2013 29,250 0
September 2013 20,500 0
August 2013 63,020 0
July 2013 20,661 0
June 2013 24,723 0
May 2013 27,661 0
April 2013 20,661 0
March 2013 62,661 0
February 2013 43,306 0
January 2013 51,122 0

There have been 489,168 shares sold, and there have been zero shares purchased by insiders since January 2013.


Fluidigm reported the third-quarter financial results on October 30 with the following highlights:

Revenue $18.3 million
Net loss $4.3 million
Cash $82.8 million


Fluidigm's 2013 guidance is as follows:

Revenue growth 32%-34%
Operating expenses $65-$68 million
Stock-based compensation expense $6-$7 million
Capital spending $4-$5 million


Fluidigm's competitors include Affymetrix (NASDAQ:AFFX), Illumina (NASDAQ:ILMN), and Life Technologies Corporation (NASDAQ:LIFE). Here is a table comparing these companies.

Company FLDM AFFX ILMN LIFE Industry Average (Scientific & Technical Instruments)
Market Cap: 944.35M 614.89M 13.73B 13.10B 384.76M
Employees: 278 1,100 2,400 10,000 1.33K
Qtrly Rev Growth (yoy): 0.43 0.01 0.25 0.03 -0.13
Revenue: 65.96M 322.11M 1.34B 3.84B 186.05M
Gross Margin: 0.69 0.55 0.68 0.66 0.46
EBITDA: -14.10M 26.96M 379.22M 1.20B 18.36M
Operating Margin: -0.25 -0.03 0.22 0.21 0.08
Net Income: -15.48M -37.97M 116.55M 476.09M N/A
EPS: -0.61 -0.53 0.84 2.72 0.92
P/E: N/A N/A 129.61 27.92 12.70
PEG (5 yr expected): -2.41 2.13 3.49 2.56 5.52
P/S: 14.29 1.88 10.38 3.41 2.07

Fluidigm has the highest P/S ratio among these four companies.

Here is a table of these competitors' insider-trading activities during the last 30 days.

Company Insider buying / shares Insider selling / shares
AFFX 0 0


LIFE 0 0

Illumina has also seen intensive insider selling during the last 30 days.


There have been four different insiders selling Fluidigm, and there have not been any insiders buying Fluidigm during the last 30 days. Three of these four insiders decreased their holdings by more than 10%. Fluidigm has an insider ownership of 0.10%.

There are five analyst buy ratings, two neutral ratings, and zero sell ratings with an average price target of $33.00. Before entering short Fluidigm, I would like to get a bearish confirmation from the Point and Figure chart. The four main reasons for the proposed short entry are bearish analyst price targets, relatively high P/S ratio, negative earnings, and the intensive insider-selling activity.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:

Tagged: , , , Scientific & Technical Instruments
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here